# Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms

> **NCT05553067** · — · COMPLETED · sponsor: **Sohag University** · enrollment: 100 (actual)

## Conditions studied

- Ovarian Neoplasms

## Interventions

- **GENETIC:** Immunohistochemical staining of normal and neoplastic ovarian tissues by anti human Engrailed-2 antibody.

## Key facts

- **NCT ID:** NCT05553067
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05553067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05553067, "Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05553067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*